W Sun1, L Sun2, F Yang1, X Zhao3, R Cai3, W Yuan4. 1. Department of Cardiology, Second Affiliated Hospital of Kunming Medical University, 374 Dianmian road, Wuhua Area, 650101, Kunming, China. 2. Department of Cardiology, Second Affiliated Hospital of Kunming Medical University, 374 Dianmian road, Wuhua Area, 650101, Kunming, China. sunlinkm@sina.com. 3. Department of Radiology, Second Affiliated Hospital of Kunming Medical University, 650101, Kunming, China. 4. Department of Radiology, First Affiliated Hospital of Chengdu Medical College, 610500, Chengdu, China.
Abstract
OBJECTIVE: Cardiovascular magnetic resonance imaging (CMR) has been established as a modality to detect myocardial viability. The aim of this study was to evaluate myocardial viability by observing transmural extent of infraction and microvascular perfusion level. METHODS: We performed CMR in 30 myocardial infarction (MI) patients within 7-10 days. At the 6‑month follow-up, CMR was used to evaluate the impact of abnormal reperfusion and observe the transmural extent of infraction on recovery of function. RESULTS: The left ventricle was divided into 16 segments using the American Heart Association classification. Infarcts were detected in 202 of the 480 segments (42%) by delayed enhancement magnetic resonance imaging (DE-MRI). According to first-pass myocardial perfusion, abnormal perfusion was detected in 278 of 480 segments (60%), reduced perfusion was identified in 173 of 278 (62%), and perfusion defects in 105 of 278 segments (38%). The results showed that the segments with abnormal perfusion were larger than in DE-MRI (P < 0.05), indicating that the area of abnormal perfusion segments extend significantly beyond the region of infarction. Microvascular perfusion with an infarcted region was lower compared to non-infarcted segments (P < 0.05). The extent of myocardial hyperenhancement correlated inversely with microvascular perfusion (P < 0.05). Segments with severe microvascular perfusion and >75% transmural infarction on the 7‑ to 10-day scan had markedly increased at the 6‑month follow-up (P < 0.01), indicating a lack of recovery of cardiac function. CONCLUSIONS: DE-MRI combined with microvascular perfusion may be effective to detect viable myocardium in patients with MI and may provide a means of predicting whether revascularization will be effective.
OBJECTIVE: Cardiovascular magnetic resonance imaging (CMR) has been established as a modality to detect myocardial viability. The aim of this study was to evaluate myocardial viability by observing transmural extent of infraction and microvascular perfusion level. METHODS: We performed CMR in 30 myocardial infarction (MI) patients within 7-10 days. At the 6‑month follow-up, CMR was used to evaluate the impact of abnormal reperfusion and observe the transmural extent of infraction on recovery of function. RESULTS: The left ventricle was divided into 16 segments using the American Heart Association classification. Infarcts were detected in 202 of the 480 segments (42%) by delayed enhancement magnetic resonance imaging (DE-MRI). According to first-pass myocardial perfusion, abnormal perfusion was detected in 278 of 480 segments (60%), reduced perfusion was identified in 173 of 278 (62%), and perfusion defects in 105 of 278 segments (38%). The results showed that the segments with abnormal perfusion were larger than in DE-MRI (P < 0.05), indicating that the area of abnormal perfusion segments extend significantly beyond the region of infarction. Microvascular perfusion with an infarcted region was lower compared to non-infarcted segments (P < 0.05). The extent of myocardial hyperenhancement correlated inversely with microvascular perfusion (P < 0.05). Segments with severe microvascular perfusion and >75% transmural infarction on the 7‑ to 10-day scan had markedly increased at the 6‑month follow-up (P < 0.01), indicating a lack of recovery of cardiac function. CONCLUSIONS: DE-MRI combined with microvascular perfusion may be effective to detect viable myocardium in patients with MI and may provide a means of predicting whether revascularization will be effective.
Entities:
Keywords:
Cardiovascular disease; Delayed enhancement magnetic resonance imaging; First-pass myocardial perfusion; Left ventricular dysfunction; Myocardial viability
Authors: L Natale; C Napolitano; A Bernardini; A Meduri; R Marano; A Lombardo; F Crea; L Bonomo Journal: Radiol Med Date: 2012-03-19 Impact factor: 3.469
Authors: Robert C Hendel; Matthias G Friedrich; Jeanette Schulz-Menger; Claudia Zemmrich; Frank Bengel; Daniel S Berman; Paolo G Camici; Scott D Flamm; Dominique Le Guludec; Raymond Kim; Massimo Lombardi; John Mahmarian; Udo Sechtem; Eike Nagel Journal: JACC Cardiovasc Imaging Date: 2016-11
Authors: R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd Journal: N Engl J Med Date: 2000-11-16 Impact factor: 91.245
Authors: Gert Klug; Agnes Mayr; Sonja Schenk; Regina Esterhammer; Michael Schocke; Michael Nocker; Werner Jaschke; Otmar Pachinger; Bernhard Metzler Journal: J Cardiovasc Magn Reson Date: 2012-07-12 Impact factor: 5.364
Authors: Stefan A J Timmer; Paul F A Teunissen; Ibrahim Danad; Lourens F H J Robbers; Pieter G H M Raijmakers; Robin Nijveldt; Albert C van Rossum; Adriaan A Lammertsma; Niels van Royen; Paul Knaapen Journal: J Nucl Cardiol Date: 2016-02-02 Impact factor: 5.952
Authors: Donya A Alhassan; Khawaja Bilal Waheed; Muhammad N Sharif; Muhammad Z Ul Hassan; Fazal Ghaffar; Khaled S Salem; Emad F M Said; Bayan M Altalaq; Ahmad O Qarmash; Zechariah J Arulanantham Journal: J Saudi Heart Assoc Date: 2020-08-17